학술논문

A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-N
Document Type
Artikel
Source
Frontiers in pediatrics. 10:836230
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
2296-2360